| Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future OO Ogunleye, D Basu, D Mueller, J Sneddon, RA Seaton, ... Frontiers in pharmacology 11, 1205, 2020 | 230 | 2020 |
| Strategies to improve antimicrobial utilization with a special focus on developing countries B Godman, A Egwuenu, M Haque, OO Malande, N Schellack, S Kumar, ... Life 11 (6), 528, 2021 | 210 | 2021 |
| Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries … B Godman, M Haque, J McKimm, M Abu Bakar, J Sneddon, J Wale, ... Current medical research and opinion 36 (2), 301-327, 2020 | 173 | 2020 |
| Non-prescription sale and dispensing of antibiotics in community pharmacies in Zambia AC Kalungia, J Burger, B Godman, JO Costa, C Simuwelu Expert review of anti-infective therapy 14 (12), 1215-1223, 2016 | 166 | 2016 |
| Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future B Godman, D Basu, Y Pillay, JC Mwita, GM Rwegerera, ... Frontiers in pharmacology 11, 108, 2020 | 133 | 2020 |
| Antimicrobial stewardship knowledge and perception among physicians and pharmacists at leading tertiary teaching hospitals in Zambia: implications for future policy and practice AC Kalungia, H Mwambula, D Munkombwe, S Marshall, N Schellack, ... Journal of chemotherapy 31 (7-8), 378-387, 2019 | 109 | 2019 |
| Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries B Godman, H McCabe, T D Leong, D Mueller, AP Martin, I Hoxha, ... Expert review of pharmacoeconomics & outcomes research 20 (1), 1-26, 2020 | 105 | 2020 |
| Biocompatibility of biomaterials for nanoencapsulation: current approaches BA Witika, PA Makoni, SK Matafwali, B Chabalenge, C Mwila, ... Nanomaterials 10 (9), 1649, 2020 | 89 | 2020 |
| Tackling antimicrobial resistance across sub-Saharan Africa: Current challenges and implications for the future B Godman, A Egwuenu, E Wesangula, N Schellack, AC Kalungia, ... Expert Opinion on Drug Safety 21 (8), 1089-1111, 2022 | 84 | 2022 |
| Rapid assessment of the potential paucity and price increases for suggested medicines and protection equipment for COVID-19 across developing countries with a particular focus … IA Sefah, OO Ogunleye, DO Essah, SA Opanga, N Butt, A Wamaitha, ... Frontiers in pharmacology 11, 588106, 2021 | 79 | 2021 |
| Key issues surrounding appropriate antibiotic use for prevention of surgical site infections in low-and middle-income countries: a narrative review and the implications JC Mwita, OO Ogunleye, A Olalekan, AC Kalungia, A Kurdi, Z Saleem, ... International journal of general medicine, 515-530, 2021 | 77 | 2021 |
| Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): A narrative review and the implications Z Saleem, B Godman, F Azhar, AC Kalungia, J Fadare, S Opanga, ... Expert review of anti-infective therapy 20 (1), 71-93, 2022 | 74 | 2022 |
| Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future B Godman, D Basu, Y Pillay, PHRF Almeida, JC Mwita, GM Rwegerera, ... Hospital practice 48 (2), 51-67, 2020 | 58 | 2020 |
| Ongoing efforts to improve antimicrobial utilization in hospitals among African countries and implications for the future Z Saleem, B Godman, A Cook, MA Khan, SM Campbell, RA Seaton, ... Antibiotics 11 (12), 1824, 2022 | 55 | 2022 |
| Challenges and innovations brought about by the COVID-19 pandemic regarding medical and pharmacy education especially in Africa and implications for the future A Etando, AA Amu, M Haque, N Schellack, A Kurdi, AA Alrasheedy, ... Healthcare 9 (12), 1722, 2021 | 55 | 2021 |
| Implications of non-prescription antibiotic sales in China A Kalungia, B Godman Lancet Infectious Diseases 19 (12), 1272-1273, 2019 | 52 | 2019 |
| Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income … B Godman, C Grobler, M Van-De-Lisle, J Wale, WB Barbosa, A Massele, ... Expert opinion on pharmacotherapy 20 (18), 2237-2255, 2019 | 52 | 2019 |
| Addressing antimicrobial resistance in Nigerian hospitals: exploring physicians prescribing behavior, knowledge, and perception of antimicrobial resistance and stewardship programs AO Babatola, JO Fadare, OS Olatunya, R Obiako, O Enwere, A Kalungia, ... Expert review of anti-infective therapy 19 (4), 537-546, 2021 | 51 | 2021 |
| Impact of the coronavirus disease (COVID-19) on the mental health and physical activity of pharmacy students at the university of Zambia: a cross-sectional study S Mudenda, M Mukosha, C Mwila, Z Saleem, AC Kalungia, ... medRxiv, 2021.01. 11.21249547, 2021 | 49 | 2021 |
| Evidence-based public policy making for medicines across countries: findings and implications for the future B Godman, J Fadare, HY Kwon, CZ Dias, A Kurdi, IP Dias Godoi, ... Journal of comparative effectiveness research 10 (12), 1019-1052, 2021 | 48 | 2021 |
Brian GodmanKarolinska Institute, Strathclyde Institute of Pharmacy and Biomedical SciencesZweryfikowany adres z briangodman.co.uk
